Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now

Learn more about CME

COPD

MoreVert
AddCircleOutlineFollow
ShareShare
AddCircleOutlineFollow
Follow
ShareShare
Share
22 Oct 2019

3-month hospital-initiated program to support patients and family caregivers with long-term self-management of COPD may increase acute care events compared to usual 30-day transitional care (JAMA 2019 Oct 8)

16 Sep 2019

adjunct moderate- or high-intensity statin therapy may not reduce all-cause mortality or exacerbations in adults with COPD (Cochrane Database Syst Rev 2019 Jul 31)

5 Sep 2019

targeted lung denervation may reduce COPD exacerbations needing hospitalization in patients with symptomatic moderate-to-severe COPD (Am J Respir Crit Care Med 2019 Aug 12 early online)

5 Sep 2019

insufficient evidence to evaluate efficacy and safety of head-to-head comparisons of prophylactic antibiotics in patients with COPD (Cochrane Database Syst Rev 2019 May 24)

28 Aug 2019

increasing air pollutant exposure associated with increased emphysema in adults in United States (JAMA 2019 Aug 13)

1 Aug 2019

Pseudomonas aeruginosa in lower respiratory tract associated with increased all-cause mortality in patients with COPD (Clin Microbiol Infect 2019 Jun 22 early online)

15 Jul 2019

addition of mindfulness-based cognitive therapy to pulmonary rehabilitation may improve symptoms of psychological distress in patients with COPD (Eur Respir J 2018 Feb)

11 Jun 2019

addition of multicomponent home-based disease management intervention to usual care may not reduce unplanned all-cause hospitalization days, but may reduce mortality in adults with severe COPD (Eur Respir J 2018 Jan 11)

11 Jun 2019

addition of case-manager-led multicomponent intervention to usual care may not reduce emergency department visits or hospital admissions, but may reduce mortality in adults with COPD and ≥ 2 COPD-associated comorbidities (Eur Respir J 2018 Jan 11)

11 Jun 2019

prophylactic oral antibiotics may decrease exacerbations in adults with moderate or severe COPD without bronchiectasis (Cochrane Database Syst Rev 2018 Oct 30)

11 Jun 2019

oral mucolytics may reduce exacerbations, hospitalization, and days of disability in adults with chronic bronchitis or chronic obstructive pulmonary disease (COPD) (Cochrane Database Syst Rev 2019 May 20)

11 Jun 2019

motivational interviewing-based health coaching may not improve COPD-related quality of life or dyspnea in adults with moderate-to-severe COPD with limited resources (Ann Am Thorac Soc 2018 Oct)

20 Mar 2019

Global Initiative for Chronic Obstructive Lung Disease (GOLD) global strategy on diagnosis, management, and prevention of COPD (GOLD 2019)

20 Mar 2019

Global Initiative for Chronic Obstructive Lung Disease (GOLD) global strategy on diagnosis, management, and prevention of COPD (GOLD 2019)

20 Mar 2019

Global Initiative for Chronic Obstructive Lung Disease (GOLD) global strategy on diagnosis, management, and prevention of COPD (GOLD 2019)

20 Mar 2019

single nurse-led advance care planning session may improve communication between patients and physicians regarding end of life care in patients with advanced COPD (Thorax 2019 Jan 19)

10 Feb 2019

both high and low blood pressures (BPs) associated with increased all-cause mortality and cardiovascular events over 2 years in patients with COPD and high cardiovascular risk (Eur Heart J 2018 Sep 1)

23 Jan 2019

inhaler education programs may reduce risk of exacerbation and increase adherence to inhaled medications in older adults with asthma and/or chronic obstructive pulmonary disease (COPD) (J Am Geriatr Soc 2019 Jan)

3 Dec 2018

hospital-initiated program combining transitional care and long-term self-management support for adults hospitalized due to COPD may reduce subsequent COPD-related hospitalization and emergency department (ED) visits (JAMA 2018 Nov 12 early online)

6 Nov 2018

shorter leukocyte telomere length associated with increased risk of death and exacerbations in patients with moderate-to-severe COPD (Chest 2018 Aug)

24 Sep 2018

review of pharmacological therapy of COPD (Chest 2018 Jul 17 early online)

22 Jun 2018

beta blockers use does not appear to change improvements compared to no beta blockers at baseline in patients with moderate to very severe COPD receiving long-acting bronchodilator treatment (Chest 2018 Jun)

22 Jun 2018

beta blockers use does not appear to change improvements compared to no beta blockers at baseline in patients with moderate to very severe COPD receiving long-acting bronchodilator treatment (Chest 2018 Jun)

22 Jun 2018

beta blockers use does not appear to change improvements compared to no beta blockers at baseline in patients with moderate to very severe COPD receiving long-acting bronchodilator treatment (Chest 2018 Jun)

22 Jun 2018

beta blockers use does not appear to change improvements compared to no beta blockers at baseline in patients with moderate to very severe COPD receiving long-acting bronchodilator treatment (Chest 2018 Jun)

22 Jun 2018

beta blockers use does not appear to change improvements compared to no beta blockers at baseline in patients with moderate to very severe COPD receiving long-acting bronchodilator treatment (Chest 2018 Jun)

5 Mar 2012

BTS recommendations on managing passengers with stable respiratory disease planning air travel (Thorax 2011 Sep)

5 Mar 2012

BTS recommendations on managing passengers with stable respiratory disease planning air travel (Thorax 2011 Sep)

5 Mar 2012

BTS recommendations on managing passengers with stable respiratory disease planning air travel (Thorax 2011 Sep)

CheckCircle
Subscribe for unlimited access to DynaMed content.
Already subscribed? Sign in

top